AKBA · Akebia Therapeutics, Inc.

$0.91 -0.05 (-5.42%) At close · Aug 26

Market Cap

$249.56M

277.11M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-05	2026-06-30
8-K	2026-08-05	—
8-K	2026-06-30	—
8-K	2026-06-22	2026-06-17
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-05-07	—
10-Q	2026-05-07	2026-03-31
DEF 14A	2026-04-28	—
8-K	2026-04-01	2026-03-27
10-K	2026-02-26	2025-12-31
8-K	2026-02-26	—
8-K	2026-01-30	2026-01-27
8-K	2026-01-12	—
8-K	2025-12-01	2025-11-28
8-K	2025-11-17	2025-11-12
10-Q	2025-11-10	2025-09-30
8-K	2025-11-10	—
8-K	2025-10-28	—
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
8-K	2025-06-13	2025-06-10
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-29	—
8-K	2025-03-20	2025-03-19
10-K	2025-03-13	2024-12-31
8-K	2025-03-13	—
8-K	2025-02-07	2025-02-03
8-K	2025-01-13	—
10-Q	2024-11-07	2024-09-30
8-K	2024-11-07	—
8-K	2024-10-22	—
8-K	2024-10-16	2024-10-15
8-K	2024-08-08	—
10-Q	2024-08-08	2024-06-30
8-K	2024-07-11	2024-07-10
8-K	2024-06-24	2024-06-21
8-K	2024-06-10	2024-06-06
10-Q	2024-05-09	2024-03-31
8-K	2024-05-09	—
DEF 14A	2024-04-25	—
8-K	2024-04-23	2024-04-17
8-K	2024-04-16	2024-04-15
8-K	2024-03-28	2024-03-27
8-K	2024-03-15	—
10-K	2024-03-14	2023-12-31
8-K	2024-03-14	—
8-K	2024-02-13	2024-02-08
8-K	2024-01-30	2024-01-29
8-K	2024-01-08	—

Showing 1–50 of 153 filings

Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 144 filings 144 filers Visit website Investor relations